Have you ever thought about getting involved in research as a patient or supporter?
In this episode, Ellie Wolmark talks to the incredible members of the Women⁺s Cancers Programme Patient and Public Involvement and Engagement (PPIE) Group about how they are involved in our research, why they think involvement is so important, and what it means to them to be a part of the group.
Not only do they share their stories and thoughts, but they also offer huge insight into their disease and the research surrounding it. They talk about how they can help and make an impact, not just for themselves and each other, but also for patients of the future. Their involvement is about making things easier, supporting quicker diagnoses, and helping to shape better, more personalised treatments.
The episode is incredibly uplifting. You will hear how empowering they find being part of the group and engaging with research. They are a shining example of how knowledge is power. Their support for one another, and for the researchers through the ups and downs of this disease, gives real hope for a better future.
Further information:
-Find out more about the DEMO Project at https://ovarian.org.uk/our-research/improve-uk/demo-uk/
-Join the Wellcome Connecting Science course on 'The Power of Patient Advocacy in Genomics: Influencing Research, Clinical Practice and Decision Making' at https://www.futurelearn.com/courses/the-power-of-patient-advocacy-in-genomics-influencing-research-clinical-practice-and-decision-making
All content for The Cancer Research UK Cambridge Centre Podcast is the property of Cancer Research UK Cambridge Centre and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Have you ever thought about getting involved in research as a patient or supporter?
In this episode, Ellie Wolmark talks to the incredible members of the Women⁺s Cancers Programme Patient and Public Involvement and Engagement (PPIE) Group about how they are involved in our research, why they think involvement is so important, and what it means to them to be a part of the group.
Not only do they share their stories and thoughts, but they also offer huge insight into their disease and the research surrounding it. They talk about how they can help and make an impact, not just for themselves and each other, but also for patients of the future. Their involvement is about making things easier, supporting quicker diagnoses, and helping to shape better, more personalised treatments.
The episode is incredibly uplifting. You will hear how empowering they find being part of the group and engaging with research. They are a shining example of how knowledge is power. Their support for one another, and for the researchers through the ups and downs of this disease, gives real hope for a better future.
Further information:
-Find out more about the DEMO Project at https://ovarian.org.uk/our-research/improve-uk/demo-uk/
-Join the Wellcome Connecting Science course on 'The Power of Patient Advocacy in Genomics: Influencing Research, Clinical Practice and Decision Making' at https://www.futurelearn.com/courses/the-power-of-patient-advocacy-in-genomics-influencing-research-clinical-practice-and-decision-making
The association between radioresistance and tumour evolution
The Cancer Research UK Cambridge Centre Podcast
45 minutes 29 seconds
3 weeks ago
The association between radioresistance and tumour evolution
Is a tumour's ability to evolve and adapt over time linked to why it becomes resistant to radiotherapy? And if so, what can we do to overcome this radioresistance?
In this episode, Dr Christopher Jones and Dr Ashley Nicholls from CRUK RadNet Cambridge at the University of Cambridge explore these questions. They explain why some tumours are resistant to radiation and why some patients are more resistant to treatment than others. They also offer insights into why recurrence happens and how to identify it early in order to treat it more effectively with new technologies.
This includes designing new tools to make drug delivery more accurate and new genetic approaches to investigate specific ways to treat cancer in the context of radiation. Chris works predominantly in oesophageal cancer, while Ash studies lung cancer, but both strive to understand why relapse and radioresistance occur to then try to target these cancers with specific drugs or drug combinations to lessen toxicity and help personalise treatment.
The Cancer Research UK Cambridge Centre Podcast
Have you ever thought about getting involved in research as a patient or supporter?
In this episode, Ellie Wolmark talks to the incredible members of the Women⁺s Cancers Programme Patient and Public Involvement and Engagement (PPIE) Group about how they are involved in our research, why they think involvement is so important, and what it means to them to be a part of the group.
Not only do they share their stories and thoughts, but they also offer huge insight into their disease and the research surrounding it. They talk about how they can help and make an impact, not just for themselves and each other, but also for patients of the future. Their involvement is about making things easier, supporting quicker diagnoses, and helping to shape better, more personalised treatments.
The episode is incredibly uplifting. You will hear how empowering they find being part of the group and engaging with research. They are a shining example of how knowledge is power. Their support for one another, and for the researchers through the ups and downs of this disease, gives real hope for a better future.
Further information:
-Find out more about the DEMO Project at https://ovarian.org.uk/our-research/improve-uk/demo-uk/
-Join the Wellcome Connecting Science course on 'The Power of Patient Advocacy in Genomics: Influencing Research, Clinical Practice and Decision Making' at https://www.futurelearn.com/courses/the-power-of-patient-advocacy-in-genomics-influencing-research-clinical-practice-and-decision-making
